Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19010 | 0.97 | — | — | |
| SCHEMBL23674271 | 0.94 | TSHR (0.40) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL16115806 | 0.94 | HTT (0.41) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL95567 | 0.94 | TSHR (0.40) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL106912 | 0.94 | — | — | |
| SCHEMBL816920 | 0.92 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL815251 | 0.92 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL815516 | 0.92 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL817953 | 0.92 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL817408 | 0.92 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2978427-B1 | FE(III) COMPLEX COMPOUNDS FOR TREATING AND PROPHYLAXIS FOR ANAEMIA SYMPTOMS AND ANAEMIA | VIFOR INT AG (CH) | 2018-08-08 | — | — | EP | disclosed |
| US-9546234-B2 | Metal fine particle dispersant, metal fine particle dispersion liquid, and cured film | HARIMA CHEMICALS, INCORPORATED (JP) | 2017-01-17 | — | — | US | disclosed |
| EP-2978427-A1 | FE(III) COMPLEXES FOR TREATMENT AND PROPHYLAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANAEMIAS | Vifor (International) AG (CH) | 2016-02-03 | — | — | EP | disclosed |
| US-9248134-B1 | Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias | VIFOR (INTERNATIONAL) AG (CH) | 2016-02-02 | — | — | US | disclosed |
| US-20160015716-A1 | Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias | VIFOR (INTERNATIONAL) AG (CH) | 2016-01-21 | — | — | US | disclosed |
| US-20160002379-A1 | METAL FINE PARTICLE DISPERSANT, METAL FINE PARTICLE DISPERSION LIQUID, AND CURED FILM | HARIMA CHEMICALS, INCORPORATED (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2962750-A1 | FINE METAL PARTICLE DISPERSANT, FINE METAL PARTICLE DISPERSED LIQUID, AND CURED FILM | Harima Chemicals, Inc. (JP) | 2016-01-06 | — | — | EP | disclosed |
| WO-2014154797-A1 | FE(III) COMPLEXES FOR TREATMENT AND PROPHYLAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANAEMIAS | VIFOR (INTERNATIONAL) AG (CH) | 2014-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160015716-A1 | Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias | FECH, SDHB, SLC40A1 | HTT 1795/4885MEN1 991/4885THRB 2329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.